Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Ginseng Research|September 12, 2024
Enhanced immunity effect of Korean Red Ginseng capsule: A randomized, double-blind and placebo-controlled clinical trialYi Yang, Jing Li, Shengyuan Zhou, et al.
Cancer Discovery|February 6, 2026
Senescence as the Next Frontier in Cancer Research: Navigating the Rising Tide of Geriatric OncologyTianxing Zhou, Jingrui Yan, Yu Zhang, et al.
European Radiology|October 24, 2023
Microwave ablation versus laparoscopic resection for hepatocellular carcinoma in patients with clinically significant portal hypertension: a propensity score-matched study of postoperative liver decompensationHongli Yu, Fenglin Zhao, Xiaoxiao Men, et al.
Cancer Biology & Medicine|March 27, 2023
Artificial intelligence-based comprehensive analysis of immune-stemness-tumor budding profile to predict survival of patients with pancreatic adenocarcinomaTianxing Zhou, Quan Man, Xueyang Li, et al.
Cancer|February 29, 2024
Triple-negative breast cancer survival prediction using artificial intelligence through integrated analysis of tertiary lymphoid structures and tumor buddingXupeng Hou, Xueyang Li, Yunwei Han, et al.
Cancer Biology & Medicine|June 29, 2023
Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinomaDanqi Fu, Jingrui Yan, Zhaoyu Zhang, et al.
Gastroenterology|March 16, 2024
Targeting ESE3/EHF With Nifurtimox Inhibits CXCR2+ Neutrophil Infiltration and Overcomes Pancreatic Cancer Resistance to Chemotherapy and ImmunotherapyYongjie Xie, Tianxing Zhou, Xueyang Li, et al.
Cancer Letters|December 22, 2024
The nuclear condensates of ESE3/EHF induce cellular senescence without the associated inflammatory secretory phenotype in pancreatic ductal adenocarcinomaTianxing Zhou, Jingrui Yan, Bohang Xu, et al.
Gut|February 10, 2026
Trogocytosis-orchestrated CLDN18.2-"dressed" CD8+ T cells drive pancreatic cancer progression via glucose metabolic reprogramming-induced cytotoxicity debilitation and systematic immune senescence cascadeTianxing Zhou, Jingrui Yan, Yu Zhang, et al.
Gut|August 26, 2024
CD64+ fibroblast-targeted vilanterol and a STING agonist augment CLDN18.2 BiTEs efficacy against pancreatic cancer by reducing desmoplasia and enriching stem-like CD8+ T cellsTianxing Zhou, Xupeng Hou, Jingrui Yan, et al.
Pageof 3